Wealth Enhancement Advisory Services LLC Purchases 1,941 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Wealth Enhancement Advisory Services LLC lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 1.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 120,504 shares of the exchange traded fund’s stock after purchasing an additional 1,941 shares during the quarter. Wealth Enhancement Advisory Services LLC owned 0.16% of SPDR S&P Biotech ETF worth $11,906,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in XBI. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of SPDR S&P Biotech ETF by 198.6% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after purchasing an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter worth about $141,284,000. Affinity Asset Advisors LLC grew its holdings in SPDR S&P Biotech ETF by 105.4% during the 2nd quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock worth $3,481,000 after acquiring an additional 737,550 shares during the last quarter. Assetmark Inc. grew its holdings in SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after acquiring an additional 588,489 shares during the last quarter. Finally, Sivik Global Healthcare LLC bought a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth about $29,640,000.

SPDR S&P Biotech ETF Stock Down 3.1 %

Shares of NYSEARCA:XBI opened at $89.44 on Monday. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The company’s 50-day moving average price is $95.48 and its two-hundred day moving average price is $97.12. The firm has a market cap of $6.82 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.